In conclusion, this study implies that CTSC may be one of the key molecular targets for promoting macrophage M1 polarization in SCD, which may provide new therapeutic insights into the treatment of inflammatory diseases. The gene discussed is CTSC; the disease is Schnyder corneal dystrophy.